Skip to main content

Table 2 Serum lipids, lipoproteins, apolipoproteins and LPL mass and LPL and HL activities in postheparin and preheparin plasma samples

From: Lipoprotein lipase activity and mass, apolipoprotein C-II mass and polymorphisms of apolipoproteins E and A5 in subjects with prior acute hypertriglyceridaemic pancreatitis

  HP
N = 24
HTG
N = 31
p
Total cholesterol 6.96 ± 3.72 6.56 ± 1.68 NS
TG 3.53 (2.07–8.75) 4.87 (2.70–8.41) NS
VLDL-Chol 0.83 ± 0.44 0.91 ± 0.47 NS
HDL-Chol 0.91 ± 0.49 0.88 ± 0.39 NS
LDL-Chol 2.95 ± 1.47 3.28 ± 1.40 NS
VLDL-TG 1.39 (1.06–1.97) 1.41 (1.10–2.32) NS
HDL-TG 0.34 (0.23–0.46) 0.31 (0.25–0.44) NS
LDL-TG 0.58 (0.42–0.64) 0.53 (0.41–0.69) NS
Chylomicron Chol 4.29 ± 5.43 2.17 ± 1.53 NS
Chylomicron TG 5.30 (2.73–11.52) 3.63 (2.30–6.40) NS
Apo A-I 1.04 ± 0.36 1.10 ± 0.30 NS
Apo B-100 0.91 ± 0.32 0.96 ± 0.27 NS
Apo CII 0.11 ± 0.05 0.13 ± 0.07 NS
Apo CIII 0.17 ± 0.07 0.20 ± 0.09 NS
Apo E 0.09 ± 0.04 0.11 ± 0.06 NS
ApoCIII/ApoCII 2.8 ± 4 1.7 ± 0.7 NS
Apo E Genotype    NS
E3/E2 1 (4) 5 (16)  
E3/E3 19 (79) 22 (73)  
E3/E4 2 (8) 3 (10)  
E2/E4 2 (8) 0  
Apo A-V, allele S19W 8 (32) 7 (23) NS
LPLactivity
(mU/ml)
69 ± 44 92 ± 44 0.057
HL-activity
(mU/ml)
164 ± 94 194 ± 84 NS
Posth-LPLmass
(ng/ml)
312 ± 192 411 ± 195 0.06
Preh-LPLmass
(ng/ml)
18 ± 11 22 ± 14 NS
  1. Data shown as mean ± SD unless Tg shown as median (IQ range). Units in SI. Note: Chylomicrons were found only in 12 subjects in the group HP and in 21 of the group HTG. Apo E and apo AV genotypes mean number (%).